Vilacto Bio (Vilacto Bio) Total Stockholders Equity : $-2.51 Mil (As of Jun. 2019)

View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Total Stockholders Equity?

Vilacto Bio's Total Stockholders Equity for the quarter that ended in Jun. 2019 was $-2.51 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Vilacto Bio's Book Value per Share for the quarter that ended in Jun. 2019 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Vilacto Bio's Debt-to-Equity for the quarter that ended in Jun. 2019 was -0.91.

Vilacto Bio Total Stockholders Equity Historical Data

The historical data trend for Vilacto Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Total Stockholders Equity Chart

Vilacto Bio Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Total Stockholders Equity

Get a 7-Day Free Trial

-0.01

-0.03

-0.04

-0.94

-3.42

Vilacto Bio Quarterly Data
	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19
Total Stockholders Equity	Get a 7-Day Free Trial															-0.88	-3.21	-4.20	-3.42	-2.51

Vilacto Bio (GREY:VIBI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Vilacto Bio's Book Value per Share for the quarter that ended in Jun. 2019 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-2.511	-	0.003)	/	1914.43
	=	-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Vilacto Bio's Debt-to-Equity for the quarter that ended in Jun. 2019 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.283	+	0)	/	-2.511
	=	-0.91

Vilacto Bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilacto Bio (Vilacto Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700

Website

https://www.vilacto.com

Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.